Mohammed Attaleb

920 total citations
49 papers, 674 citations indexed

About

Mohammed Attaleb is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Mohammed Attaleb has authored 49 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Mohammed Attaleb's work include Cervical Cancer and HPV Research (19 papers), Epigenetics and DNA Methylation (11 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Mohammed Attaleb is often cited by papers focused on Cervical Cancer and HPV Research (19 papers), Epigenetics and DNA Methylation (11 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Mohammed Attaleb collaborates with scholars based in Morocco, France and Switzerland. Mohammed Attaleb's co-authors include Mohammed El Mzibri, Meriem Khyatti, Laïla Benbacer, M. Amrani, Moulay Mustapha Ennaji, Hamid Morjani, Youssef Bakri, Jean Baptiste Mazarati, Nawal Merghoub and Saaïd Amzazi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Gene.

In The Last Decade

Mohammed Attaleb

47 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed Attaleb Morocco 17 272 249 190 156 151 49 674
Sreevidya Santha United States 14 189 0.7× 295 1.2× 127 0.7× 72 0.5× 56 0.4× 24 558
Asmita Pal India 6 175 0.6× 206 0.8× 111 0.6× 74 0.5× 46 0.3× 9 437
Leticia Rocha‐Zavaleta Mexico 18 236 0.9× 357 1.4× 257 1.4× 180 1.2× 52 0.3× 61 941
Soo Jong Um South Korea 12 265 1.0× 233 0.9× 84 0.4× 54 0.3× 87 0.6× 15 495
M. Amrani Morocco 14 92 0.3× 126 0.5× 153 0.8× 91 0.6× 84 0.6× 44 480
Stéphanie Villar France 17 144 0.5× 247 1.0× 177 0.9× 288 1.8× 135 0.9× 34 752
Shan‐Ying Wu Taiwan 17 369 1.4× 523 2.1× 99 0.5× 292 1.9× 57 0.4× 37 882
Kanchan Vishnoi India 12 96 0.4× 317 1.3× 190 1.0× 188 1.2× 25 0.2× 17 578
Zhentong Wei China 13 118 0.4× 348 1.4× 111 0.6× 98 0.6× 28 0.2× 33 585
Yanbin Chen China 16 71 0.3× 274 1.1× 125 0.7× 161 1.0× 52 0.3× 35 578

Countries citing papers authored by Mohammed Attaleb

Since Specialization
Citations

This map shows the geographic impact of Mohammed Attaleb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Attaleb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Attaleb more than expected).

Fields of papers citing papers by Mohammed Attaleb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Attaleb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Attaleb. The network helps show where Mohammed Attaleb may publish in the future.

Co-authorship network of co-authors of Mohammed Attaleb

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Attaleb. A scholar is included among the top collaborators of Mohammed Attaleb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Attaleb. Mohammed Attaleb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassan, I., Abderrahmane Al Bouzidi, Laïla Benbacer, et al.. (2025). STAT1 and STAT4 expression as prognostic biomarkers in patients with bladder cancer. Molecular and Clinical Oncology. 22(4). 33–33. 1 indexed citations
2.
Bouzidi, Abderrahmane Al, et al.. (2025). Exploring the role of transcription factor TWIST1 in bladder cancer progression. Cancer Genetics. 292-293. 44–48. 1 indexed citations
3.
Bensaid, Mounia, Abderrahmane Al Bouzidi, Mohamed Oukabli, et al.. (2024). Comprehensive behavioural assessment of TERT in bladder cancer. Urologic Oncology Seminars and Original Investigations. 42(12). 451.e19–451.e29. 3 indexed citations
4.
Bendahhou, Karima, et al.. (2023). Genetic Polymorphisms in ERCC1 Gene and Their Association with Response to Radiotherapy in Moroccan Patients with Nasopharyngeal Carcinoma. Asian Pacific Journal of Cancer Prevention. 24(1). 93–99. 3 indexed citations
5.
Benbacer, Laïla, Mounia Bensaid, Mohamed Oukabli, et al.. (2023). The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer. Diagnostics. 13(8). 1471–1471. 3 indexed citations
6.
Benbacer, Laïla, Mounia Bensaid, Mohamed Oukabli, et al.. (2022). Exploring urine sediments as a non-invasive method for DNA methylation detection in bladder cancer. African Journal of Urology. 28(1). 2 indexed citations
7.
El‐Abid, Hassan, et al.. (2020). HPV16 L1 diversity and its potential impact on the vaccination-induced immunity. Gene. 747. 144682–144682. 12 indexed citations
8.
Attaleb, Mohammed, et al.. (2018). CHEK2 Germ Line Mutations are Lacking among Familialand Sporadic Breast Cancer Patients in Rwanda. PubMed. 19(2). 375–379. 4 indexed citations
9.
Attaleb, Mohammed, et al.. (2017). Association of p53 Codon 72 Polymorphism with Breast Cancer in a Rwandese Population. Pathobiology. 85(3). 186–191. 8 indexed citations
10.
11.
Attaleb, Mohammed, et al.. (2014). Absence of CHEK2 1100delC, R145W and I157T Mutations in Breast Cancer in a Moroccan Population. 2(1). 6–9. 5 indexed citations
12.
Razıne, Rachid, et al.. (2014). Breast Cancer in Morocco: A Literature Review. Asian Pacific Journal of Cancer Prevention. 15(3). 1067–1074. 25 indexed citations
13.
Khyatti, Meriem, Mohamed Berraho, Moulay Mustapha Ennaji, et al.. (2013). Analysis of mutations in the E6 oncogene of human papillomavirus 16 in cervical cancer isolates from Moroccan women. BMC Infectious Diseases. 13(1). 378–378. 31 indexed citations
14.
Attaleb, Mohammed, et al.. (2013). No evidence of correlation between p53 codon 72 polymorphism and risk of bladder cancer in Moroccan patients. Clinical Cancer Investigation Journal. 2(4). 302–302. 1 indexed citations
15.
Ameziane-El-Hassani, Rabii, et al.. (2013). Human papillomavirus detection in Moroccan patients with bladder cancer. The Journal of Infection in Developing Countries. 7(8). 586–592. 20 indexed citations
16.
Attaleb, Mohammed, et al.. (2010). Identification of G2607A mutation in EGFR gene with a significative rate in Moroccan patients with nasopharyngeal carcinoma.. PubMed. 56 Suppl. OL1442–6. 7 indexed citations
17.
Amrani, M., et al.. (2010). EGFR, p16INK4a and E-cadherin immuno-histochemistry and EGFR point mutations analyses in invasive cervical cancer specimens from Moroccan women.. PubMed. 56 Suppl. OL1373–84. 11 indexed citations
18.
Mzibri, Mohammed El, et al.. (2009). Prevalence of Human Papilloma Virus Infection in Malignant Lesions of the Uterine Cervix in Morocco. World Journal of Nuclear Medicine. 8(3). 192–196. 2 indexed citations
19.
Attaleb, Mohammed, Meriem Khyatti, Laïla Benbacer, et al.. (2009). Status of p16<SUP>INK4a</SUP> and E-Cadherin Gene Promoter Methylation in Moroccan Patients With Cervical Carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 18(4). 185–192. 18 indexed citations
20.
Attaleb, Mohammed, et al.. (1999). High resolution mapping of chromosome 6 deletions in cervical cancer.. Oncology Reports. 6(4). 859–63. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sreevidya Santha Breakdown of academic impact, for papers by Asmita Pal Breakdown of academic impact, for papers by Leticia Rocha‐Zavaleta Breakdown of academic impact, for papers by Soo Jong Um Breakdown of academic impact, for papers by M. Amrani Breakdown of academic impact, for papers by Stéphanie Villar Breakdown of academic impact, for papers by Shan‐Ying Wu Breakdown of academic impact, for papers by Kanchan Vishnoi Breakdown of academic impact, for papers by Zhentong Wei Breakdown of academic impact, for papers by Yanbin Chen
Rankless by CCL
2026